Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>DLBCL R/R*** > USA. P. Brentuximab Vedotin+

---

USA. P. Brentuximab Vedotin+'s subsections
(*) USA Approval Date: 2025. 02.12
+Lenalidomide+Rituximab
Company
RTM
RTM Web-Site
USA Patent Numbers

USA. P. Brentuximab Vedotin+'s products
This section has no products